FSEIX | JVMAX | FSEIX / JVMAX | |
Total Expense Ratio | 0.88 | 1.12 | 79% |
Annual Report Gross Expense Ratio | 0.97 | 1.13 | 86% |
Fund Existence | 31 years | 28 years | - |
Gain YTD | -10.672 | -8.576 | 124% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 100000 | 1000 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 357M | 19.4B | 2% |
Annual Yield % from dividends | 1.21 | 0.61 | 197% |
Returns for 1 year | -6.33 | -11.80 | 54% |
Returns for 3 years | -7.66 | -9.16 | 84% |
Returns for 5 years | 60.76 | 45.43 | 134% |
Returns for 10 years | 43.05 | 18.32 | 235% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.45 | -3.02% |
YieldMax AMZN Option Income Strategy ETF |